Your session is about to expire
← Back to Search
Corticosteroid
Experimental for Torn Meniscus (SLAM Trial)
Phase 2
Waitlist Available
Research Sponsored by Austin V Stone
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 4 months, 1 year, 2 years
Awards & highlights
SLAM Trial Summary
This trial will study if a certain medication can help prevent changes in bone shape after ACL surgery.
Eligible Conditions
- Torn Meniscus
- Anterior Cruciate Ligament Tear
SLAM Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 4 months, 1 year, 2 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 4 months, 1 year, 2 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Bone Shape (Baseline to 4 Months)
Secondary outcome measures
Change in CTXII (Baseline to 4 Months)
Change in ICOAP (Baseline to 1 Year)
Change in ICOAP (Baseline to 2 Years)
+7 moreSide effects data
From 2021 Phase 4 trial • 70 Patients • NCT0389584011%
Fall
10%
arthralgia
6%
URI
4%
Bruising
3%
headache
3%
Swelling
1%
Hyperglycemia
1%
Epistaxis
1%
Hematuria
1%
Flu-like symptoms
1%
Rhinorrea
1%
Otitis media
1%
Blister
1%
Allergic rhinitis
100%
80%
60%
40%
20%
0%
Study treatment Arm
Intra-articular Zilretta Injection
SLAM Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: ExperimentalExperimental Treatment1 Intervention
The experimental group will receive a single 32 mg Zilretta injection approximately 8 weeks after meniscus surgery.
Group II: PlaceboPlacebo Group1 Intervention
The placebo group will receive a single 5 mL injection of normal saline approximately 8 weeks after meniscus surgery.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Zilretta
2018
Completed Phase 4
~70
Find a Location
Who is running the clinical trial?
Austin V StoneLead Sponsor
4 Previous Clinical Trials
73 Total Patients Enrolled
Austin Stone, MD, PhDStudy DirectorUniversity of Kentucky
3 Previous Clinical Trials
68 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger